Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2005
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
10/05/2005CN1221259C Preparation method of medicine for curing urteriosclerosis by using CS-866, losartan and candisartan
10/05/2005CN1221257C Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treatment of neurogenic inflammation
10/05/2005CN1221256C 药物组合物 The pharmaceutical composition of
10/05/2005CN1221254C New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation
10/05/2005CN1221190C Composition and method for smoke detoxification
10/04/2005US6951942 Glucocorticoid-selective anti-inflammatory agents
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951938 Aryl fused azapolycyclic compounds
10/04/2005US6951937 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
10/04/2005US6951934 Method for preparing functionalized β-(1,3)-glucan derivatives
10/04/2005US6951923 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
10/04/2005US6951918 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
10/04/2005US6951916 Melanocortin receptor ligands
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951887 Lipoic acid derivatives and their use in treatment of disease
10/04/2005US6951884 Fluorobenzamides and uses thereof
10/04/2005US6951883 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof
10/04/2005US6951877 Materials and methods for treating hypercholesterolemia
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951875 Conjugated aromatic compounds with a pyridine substituent
10/04/2005US6951874 Compounds
10/04/2005US6951872 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
10/04/2005US6951871 Indole derivatives useful as histamine H3 antagonists
10/04/2005US6951868 Central nervous system disorders, gastrointestinal disorders;side effect reduction
10/04/2005US6951858 Substituted 1,2,4-triazine-3,5-diones; male and female sex hormone related conditions
10/04/2005US6951857 Interleukins; cytokines; for treating eosinophil-dependent inflammatory disease/bronchial asthma
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005US6951855 vascular damaging agents
10/04/2005US6951850 Dipeptide derivatives
10/04/2005US6951843 Peptide derivatives and their pharmaceutically acceptable salts, thereof, processes for preparation of both and use thereof
10/04/2005US6951735 Death domain containing receptors
10/04/2005CA2245539C Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
09/2005
09/30/2005CA2499791A1 Angptl4/fiaf as marker for ppardelta modulation
09/29/2005WO2005090574A1 Vascular endothelial growth inhibiting gene
09/29/2005WO2005090368A1 Synthetic membrane anchors
09/29/2005WO2005090332A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005WO2005090328A1 Heterocyclic compound and use thereof
09/29/2005WO2005090285A1 Novel crystal of triterpene derivative
09/29/2005WO2005089802A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
09/29/2005WO2005089801A1 Method of preventing ultraviolet ray-induced apoptosis
09/29/2005WO2005089799A1 Cytotoxicity method using effector function of anti-fam3d antibody
09/29/2005WO2005089788A1 Medicine for cancer therapy
09/29/2005WO2005089785A1 Acerola leaf extract-containing blood sugar level increase inhibitor and age formation inhibitor, and food containing them
09/29/2005WO2005089783A1 Lipoprotein lipase activity inhibitor
09/29/2005WO2005089714A1 Emulsion stabilizer
09/29/2005WO2003076469A9 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/29/2005US20050215786 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,,2,4-triazol-3-one
09/29/2005US20050215645 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction
09/29/2005US20050215620 Method of treating amyloid beta precursor disorders
09/29/2005US20050215617 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
09/29/2005US20050215613 with indazole or thienopyrazole compounds such as 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl-indazole
09/29/2005US20050215612 Anticancer agents; such as succinic acid mono-[5-(1-benzyl-1H-indazol-3-yl)-furan-2-ylmethyl]ester, sodium salt; inhibit cancer cell growth
09/29/2005US20050215607 Drug composition for prevention or inhibition of advance of diabetic complication
09/29/2005US20050215605 Preterm labor, premature birth, dysmenorrhea; inhibitors of the prostaglandin F2 alpha receptor; e.g. 3-([1,1'-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide
09/29/2005US20050215598 Phenylalanine derivatives
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215592 Methods for assessing, improving, or maintaining urogenital health in postmenopausal woman
09/29/2005US20050215574 4-anilino quinazoline derivatives as antiproliferative agents
09/29/2005US20050215559 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders
09/29/2005US20050215557 For therapy and prophylaxis of inflammatory diseases, asthma, atopic dermatitis, urticaria, allergic diseases, nephritis, nephropathy, hepatitis, arthritis or rheumatoid arthritis etc
09/29/2005US20050215550 Pyrazole-derived kinase inhibitors and uses thereof
09/29/2005US20050215549 TACE inhibitors
09/29/2005US20050215547 Optically active pyridine derivative and a medicament containing the same
09/29/2005US20050215537 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
09/29/2005US20050215534 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease; dermatitis; antiallergens; antitumor agents; Aida; antiischemic agents; arrhythmia
09/29/2005US20050215533 Administering to mammal an effective amount of sulfaphenazole wherein the administered sulfaphenazole substantially reduces the amount of infracted tissue
09/29/2005US20050215530 Combination therapy for the treatment of cancer
09/29/2005US20050215528 Gnrh agonist combination drugs
09/29/2005US20050215509 Method for inhibiting jnk-1 kinase activity by SCCA
09/29/2005US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens
09/29/2005US20050215497 Treating prostate cancer by administering double stranded oligonucleotide having two complementary oligonucleotide sequences forming a hybrid; each sequence has at one 3' or 5' end 1-5 unpaired nucleotides forming single-strand ends extending beyond the hybrid
09/29/2005US20050215493 Calcium-containing tissue strengthening agents and use thereof
09/29/2005US20050215480 Alpha conotoxin peptides with analgesic properties
09/29/2005US20050215477 Treating agonist disorderssuch asd diabetes, obesity, heart dysfunctions, AIDS-related wasting, and kidney, neurological, whole body growth disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern
09/29/2005US20050214943 Transcription factors; nuclear localization peptides; signal sequences; NF-kappaB/Rel proteins; modulating expression of a gene
09/29/2005US20050214910 Chordin-like molecules and uses thereof
09/29/2005US20050214903 O-superfamily conotoxin peptides
09/29/2005US20050214856 Nucleotide sequences coding bone morphogenic protein for identifying modulators for treatment of bone diseases
09/29/2005US20050214844 Nucleotide sequences coding translocation protein for use in identifying modulators for prevention and treatment of cell proliferative ,inflammatory and autoimmune disorders
09/29/2005US20050214830 Recombinant g protein coupled receptor for use in identifying modulators for prevention and treatment of cell proliferative disorders
09/29/2005US20050214795 Polypeptide for use as diagnostic indicator of cell proliferative disorders; immunotherapeutics; antitumor agents
09/29/2005US20050214392 Treatments for immune systems disorders
09/29/2005US20050214384 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
09/29/2005US20050214330 Process for producing sustained-release composition
09/29/2005US20050214320 Mycobacterium vaccae; enhancement of immune Th1 or Th2 responses to heterologous antigens; tuberculosis, autoimmune thyroiditis, insulin-dependent diabetes mellitus, multiple sclerosis, Crohn's disease, peptic ulcers, organ transplant rejection, sarcoidosis, asthma, allergic rhinitis, cancer, lupus
09/29/2005US20050214293 Containing heavy and light chain complementarity determining region 1,2 and 3 components of amino acid sequences 1-6; reduced immunogenicity; increased affinity and avidity; improved cell culturing
09/29/2005US20050214281 G-protein coupled receptor
09/29/2005US20050214272 Antiinflammatory agents for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome
09/29/2005US20050214270 Lactobacillus acidophilus and/or fermentum; reducing immunoglobulin E levels; safe, easy to take
09/29/2005US20050214252 Chordin-like molecules and uses thereof
09/29/2005DE10393402T5 Mittel und Toilettenartikel- oder pharmazeutische Zusammensetzung zum Beschleunigen der Aufnahme von basischen Aminosäuren in Zellen Means and Toilettenartikel- or pharmaceutical composition to accelerate the uptake of basic amino acids in cells
09/29/2005CA2562388A1 Emulsion-stabilized preparation
09/29/2005CA2560953A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
09/29/2005CA2560767A1 Novel crystal of triterpene derivative
09/29/2005CA2560286A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005CA2558126A1 The treatment of inflammatory disorders and pain using beta-aminoalcohols
09/28/2005EP1580556A1 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration
09/28/2005EP1580216A1 High-molecular weight derivatives of camptothecins
09/28/2005EP1580188A1 Aryl ureas as kinase inhibitors
1 ... 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 ... 1564